ArticleFrontiers in surgery2026
Comparative analysis of unilateral biportal endoscopy and minimally invasive transforaminal lumbar interbody fusion in treating lumbar spinal brucellosis.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to compare the clinical efficacy and safety of unilateral biportal endoscopy-assisted transforaminal lumbar interbody fusion (UBE-TLIF) vs. minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in the treatment of lumbar spinal brucellosis, with the goal of identifying an optimized surgical strategy. Methods: A retrospective analysis was conducted on 62 patients with lumbar spinal brucellosis who underwent surgery between January 2018 and June 2024. Patients were divided into two groups based on the surgical approach: UBE-TLIF ( Results: The two groups were comparable in baseline characteristics ( Conclusion: Both UBE-TLIF and MIS-TLIF are safe and effective surgical options for lumbar spinal brucellosis, providing adequate infection control, pain relief, functional restoration, and satisfactory bone fusion. UBE-TLIF offers superior minimally invasive benefits, including shorter operative time, reduced blood loss, less surgical trauma, and enhanced early postoperative pain control, supporting its preferential application in appropriately selected patients by surgeons with relevant expertise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.